Peter Attia· MD
there's a lot of people who have what's considered a physiologic or a non-adversarial concentration of LP little a in your system so you don't have to make it go to zero you know where risk is concerned
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there's a lot of people who have what's considered a physiologic or a non-adversarial concentration of LP little a in your system so you don't have to make it go to zero you know where risk is concerned
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so the penetrance is the proportion of individuals with a certain genotype that will have the femoral disease exactly so the penetrance is obviously not a hundred percent right